Drug factory · FDA FEI 3002806438
Pfizer Canada ULC
720 17th St E, Brandon, Canada
No problems found at FDA's last inspection, Aug 3, 2023.
No Action Indicated: inspectors found no objectionable conditions.
4 drug inspections on record since 2010: 4 with no problems, 0 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Bazedoxifene and Estrogens, Conjugated | Makes the active ingredient and tests it | U.S. Pharmaceuticals, Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 63539-122, 0008-1123 |
| Estrogens, Conjugated | Makes the active ingredient and tests it | Prasco Laboratories, Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 66993-295, 66993-296, 66993-297 +9 |
| Estrogens, Conjugated and Medroxyprogesterone | Makes the active ingredient and tests it | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 0046-1105, 0046-1106, 0046-1107 +2 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Aug 3, 2023 | No problems found | Drug Quality Assurance | — |
| Feb 12, 2016 | No problems found | Drug Quality Assurance | — |
| Mar 7, 2013 | No problems found | Drug Quality Assurance | — |
| Mar 18, 2010 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.